Literature DB >> 16793814

ABC of chronic obstructive pulmonary disease. Pharmacological management--oral treatment.

Graeme P Currie1, Daniel K C Lee, Brian J Lipworth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793814      PMCID: PMC1482343          DOI: 10.1136/bmj.332.7556.1497

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review.

Authors:  P J Poole; P N Black
Journal:  BMJ       Date:  2001-05-26

Review 2.  Theophylline: new perspectives for an old drug.

Authors:  Peter J Barnes
Journal:  Am J Respir Crit Care Med       Date:  2003-03-15       Impact factor: 21.405

Review 3.  Treatment of stable chronic obstructive pulmonary disease.

Authors:  Stephen I Rennard
Journal:  Lancet       Date:  2004 Aug 28-Sep 3       Impact factor: 79.321

4.  Salmeterol plus theophylline combination therapy in the treatment of COPD.

Authors:  R L ZuWallack; D A Mahler; D Reilly; N Church; A Emmett; K Rickard; K Knobil
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

Review 5.  Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease.

Authors:  Brian J Lipworth
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

Review 6.  Oral theophylline for chronic obstructive pulmonary disease.

Authors:  F S Ram; P W Jones; A A Castro; J A De Brito; A N Atallah; Y Lacasse; R Mazzini; R Goldstein; S Cendon
Journal:  Cochrane Database Syst Rev       Date:  2002
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.